|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
Regenerative reads: brain organoids, Clinicaltrials.gov change
|
|
|
Sometimes change takes a very long time, but with brain organoids or advocating for better information for patients at Clinicaltrials.gov, after waiting you can see some interesting developments. These are two of the regenerative medicine stories of the week, along with some striking research papers. Clinicaltrials.gov Some of us have been advocating for improvements at Clinicaltrials.gov for a long time. …
|
|
|
|
|
|
24 cell therapy & stem cell stocks I'm following
|
|
|
Stem cell stocks, meaning cellular therapy biotech companies, face many challenges, but their clinical research is crucial. These biotechs have ups and downs, sometimes at the same time. This is kind of the standard of "life" as any biotech company. It is definitely the case in the volatile stem cell and cell therapy arena. Today I'm highlighting 24 "stem cell …
|
|
|
|
|
|
Recommended reads: stem cells on the brain, heart, COVID
|
|
|
There are weeks when it seems like papers on stem cells keep popping up. It can be a challenge to keep up with reading all the papers you want to read. Other times it is cell biology news that keeps breaking. The big news of the past week or so was unfortunately the concerning development on the halt of BlueBird …
|
|
|
|
|
|
Fact-Checking Panama stem cell institute: cost, safety, efficacy, docs
|
|
|
Somehow time has flown by so that I've been around for ages in the stem cell universe and some unproven stem cell clinic type firms, like the well-known Panama stem cell clinic that sells autism "treatments", are also long-timers. It's been an odd parallel existence for more than a decade. Both the Panama clinic place, run by Neil Riordan and …
|
|
|
|
|
|
Bluebird bio sickle cell gene therapy trial halted on cancer worry
|
|
|
Recently I was going through a list I'm updating of regenerative medicine biotech companies including Bluebird bio. Now just a few days later the world seems turned upside down for the firm and maybe to some degree for other companies doing related work. Bluebird bio blues: 2 trial participants get cancer News broke today that Bluebird Bio had to halt …
|
|
|
|
|